Harpoon Therapeutics Inc (HARP) has released an update to notify the public and investors about corporate charter and bylaws modifications.
Harpoon Therapeutics, Inc. amended its Certificate of Designation for its 8.000% Series A Redeemable Preferred Stock to incorporate changes from a one-for-ten reverse stock split of its common stock that took place on September 1, 2023. This amendment was filed with the Secretary of State of Delaware on January 26, 2024.
For further insights into HARP corporate activity, check out TipRanks’ Insiders Trading Activity page.
